Akari Therapeutics, Plc (AKTX)

Etorro trading 970x250
Akari Therapeutics, Plc (AKTX) Logo

About Akari Therapeutics, Plc

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for a range of rare and orphan autoimmune and inflammatory diseases. Its lead product candidate is Coversin, a second-generation complement inhibitor that is in Phase II clinical trial for the treatment of autoimmune and inflammatory diseases, including paroxysmal nocturnal hemoglobinuria, guillain barré syndrome, and atypical hemolytic uremic syndrome. Akari Therapeutics, Plc is based in London, the United Kingdom. Address: 75/76 Wimpole Street, London, United Kingdom, W1G 9RT

Akari Therapeutics, Plc News and around…

Latest news about Akari Therapeutics, Plc (AKTX) common stock and company :

Akari Therapeutics to Present at the Cantor Virtual Global Healthcare Conference
22 Sep, 2021 FinancialContent
Akari Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Clinical Progress
22 Sep, 2021 FinancialContent
Akari Therapeutics to Present Its Phase III Plans for Nomacopan in Patients with Bullous Pemphigoid at the 2021 International Pemphigus & Pemphigoid Foundation (IPPF) Scientific Symposium
10 Sep, 2021 FinancialContent
Akari Therapeutics to Present at the H.C. Wainwright Global Investment Conference
07 Sep, 2021 FinancialContent
Akari Therapeutics Announces Private Placement
07 Jul, 2021 FinancialContent
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
07 Jul, 2021 FinancialContent

Gainers Dare Bioscience (NASDAQ:DARE) shares increased by 51.97% to $2.31 during Wednesday's pre-market session. The ...

Akari Therapeutics Reports Q1 2021 Financial Results and Highlights Recent Clinical Progress
29 Jun, 2021 FinancialContent
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
04 May, 2021 FinancialContent

Gainers BioLine Rx (NASDAQ:BLRX) shares moved upwards by 65.2% to $5.27 during Tuesday's pre-market session. The ...

Akari Therapeutics' Nomacopan Secures Expediated Review Tag For Blistering Skin Disorder
28 Apr, 2021 FinancialContent

TheFDA has granted Fast Track designationtoAkari Therapeutics Plc's(NASDAQ:AKTX) nomacopan to treat ...

Akari Therapeutics Receives FDA Fast Track Designation for Nomacopan for the Treatment of Bullous Pemphigoid
28 Apr, 2021 FinancialContent
Akari Therapeutics Announces Poster Presentation of Phase II Bullous Pemphigoid Disease and Phase III Trial Design at American Academy of Dermatology Association Virtual Meeting Experience
22 Apr, 2021 FinancialContent
Akari Therapeutics Reports Full Year 2020 Financial Results and Highlights Recent Clinical Progress
20 Apr, 2021 FinancialContent
12 Health Care Stocks Moving In Monday's After-Market Session
19 Apr, 2021 FinancialContent

Gainers Obalon Therapeutics (NASDAQ:OBLN) shares moved upwards by 6.04% to $2.63 during Monday's after-market session. At the ...

25 Stocks Moving in Tuesday's Pre-Market Session
13 Apr, 2021 FinancialContent

Gainers Dragon Victory International Limited (NASDAQ: LYL) rose 52.1% to $2.16 in pre-market trading after dropping around 8% on ...

Akari Therapeutics' To Go With Pivotal Bullous Pemphigoid Study With Nomacopan
12 Apr, 2021 FinancialContent

The FDA hasopened the investigational new drug applicationfor Phase 3 trial forAkari Therapeutics ...

42 Stocks Moving In Monday's Mid-Day Session
12 Apr, 2021 FinancialContent

Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 44.8% to $8.05 after the company's 13D filing showed that ...

Akari Therapeutics Announces Initiation of Pivotal Phase III Trial of Nomacopan in Bullous Pemphigoid (BP)
12 Apr, 2021 FinancialContent
12 Health Care Stocks Moving In Friday's Pre-Market Session
05 Mar, 2021 FinancialContent

Gainers XTL Biopharmaceuticals (NASDAQ:XTLB) shares increased by 102.76% to $5.86 during Friday's pre-market ...

12 Health Care Stocks Moving In Thursday's After-Market Session
04 Mar, 2021 FinancialContent

Gainers Fulgent Genetics (NASDAQ:FLGT) stock moved upwards by 29.19% to $110.5 during Thursday's after-market session. This ...

Akari Therapeutics Announces a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR) for Nomacopan in Trauma
04 Mar, 2021 FinancialContent

Study of porcine model of blast injury and haemorrhagic shock underway with USAISR as part of the development of a clinical path for the use of nomacopan to treat trauma

Akari Therapeutics' PASylated Nomacopan Shows Promising Action In Animal Studies
25 Feb, 2021 FinancialContent

Akari Therapeutics Plc(NASDAQ:AKTX)announces new datafrom PASylated nomacopan published in the journal ...

Akari Therapeutics Presents New Preclinical Data Highlighting Potential of Long-Acting PASylated Nomacopan to Treat Retinal Diseases, Including Age-Related Macular Degeneration (AMD) and Uveitis
25 Feb, 2021 FinancialContent
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
23 Feb, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

80 Biggest Movers From Friday
22 Feb, 2021 FinancialContent

Gainers Energous Corporation (NASDAQ: WATT) shares surged 94.4% to close at $7.23 on Friday following Bloomberg report Apple is ...

Is Akari Therapeutics, Plc (NASDAQ:AKTX) Popular Amongst Insiders?
02 Feb, 2021 Yahoo! Finance

A look at the shareholders of Akari Therapeutics, Plc ( NASDAQ:AKTX ) can tell us which group is most powerful...

Akari Therapeutics Adds Histamine Inhibitor Votucalis to Pipeline to treat Neuropathic Pain and Dermatological Disease
01 Feb, 2021 FinancialContent
101 Biggest Movers From Yesterday
29 Jan, 2021 FinancialContent

Gainers New Concept Energy, Inc. (NYSE: GBR) shares jumped 959.3% to close at $25.00 on Thursday. Marine Petroleum Trust ...

The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
21 Jan, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
20 Jan, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

54 Biggest Movers From Friday
19 Jan, 2021 FinancialContent

Gainers Yield10 Bioscience, Inc. (NASDAQ: YTEN) shares jumped 76.9% to close at $13.71 on Friday. ObsEva SA (NASDAQ: OBSV) ...

Akari Therapeutics, Plc (AKTX) is a NASDAQ Common Stock listed in , ,

970x250